Expression of CD4 + forkhead box P3 (FOXP3) + regulatory T cells in inflammatory bowel disease

Journal of Digestive Diseases

Volumn 12, Issue 4, 2011, Pages 286-294

  Wang, Yi ^a   Liu, Xue Ping ^a   Zhao, Zhi Bin ^a   Chen, Jun Hao ^a   Yu, Cheng Gong ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

FOXP3 protein; Immunohistochemistry; Inflammatory bowel disease; Regulatory T lymphocyte

Indexed keywords

CD4 ANTIGEN; MESSENGER RNA; PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD4+ FOXP3+ T LYMPHOCYTE; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; ULCERATIVE COLITIS; WESTERN BLOTTING;

ADULT; ANTIGENS, CD4; BIOPSY; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY;

EID: 79960705112     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2011.00505.x     Document Type: Article

References (41)

1. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002; 20: 495-549.
2. Blumberg RS, Strober W. Prospects for research in inflammatory bowel disease. JAMA 2001; 285: 643-7.
3. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, ZumBuschenfelde KHM. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995; 102: 448-55.
4. Probert CS, Chott A, Turner JR etal. Persistent clonal expansions of peripheral blood CD4(+) lymphocytes in chronic inflammatory bowel disease. J Immunol 1996; 157: 3183-91.
5. Soderholm JD, Peterson KH, Olaison G etal. Epithelial permeability to proteins in the noninflamed ileum of Crohn's disease? Gastroenterology 1999; 117: 65-72.
6. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 2001; 193: 1303-10.
7. Miller J, Heath WR. Self-ignorance in the peripheral T cell pool. Immunol Rev 1993; 133: 131-50.
8. Rocha B, Vonboehmer H. Peripheral selection of the T cell repertoire. Science 1991; 251: 1225-8.
9. Schwartz RH. A cell culture model for lymphocyte T clonal anergy. Science 1990; 248: 1349-56.
10. Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol 2006; 24: 209-26.
11. Ehrenstein MR, Evans JG, Singh A etal. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF alpha therapy. J Exp Med 2004; 200: 277-85.
12. Miyara M, Amoura Z, Parizot C etal. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006; 203: 359-70.
13. Saruta M, Yu QT, Fleshner PR etal. Characterization of FOXP3(+)CD4(+) regulatory T cells in Crohn's disease. Clin Immunol 2007; 125: 281-90.
14. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4(+)CD25(+) regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199: 971-9.
15. Bennett CL, Ochs HD. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr Opin Pediatr 2001; 13: 533-8.
16. Wildin RS, Ramsdell F, Peake J etal. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001; 27: 18-20.
17. Kasprowicz DJ, Smallwood PS, Tyznik AJ, Ziegler SF. Scurfin (FOXP3) controls T-dependent immune responses in vivo through regulation of CD4(+) T cell effector function. J Immunol 2003; 171: 1216-23.
18. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor FOXP3. Science 2003; 299: 1057-61.
19. Yagi H, Nomura T, Nakamura K etal. Crucial role of FOXP3 in the development and function of human CD25(+)CD4(+) regulatory T cells. Int Immunol 2004; 16: 1643-56.
20. Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through FOXP3 induction and down-regulation of Smad7. J Immunol 2004; 172: 5149-53.
21. Sakaguchi S. Naturally arising CD4(+) regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531-62.
22. Holmen N, Lundgren A, Lundin S etal. Functional CD4(+)CD25(high) regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflamm Bowel Dis 2006; 12: 447-56.
23. Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F. CD4(+)CD25(+) T-R cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003; 197: 111-9.
24. Wing K, Suri-Payer E, Rudin A. CD4(+)CD25(+)-regulatory T cells from mouse to man. Scand J Immunol 2005; 62: 1-15.
25. Best WR, Becktel JM, Singleton JW. Rederived values the 8 coefficients of the Crohn disease activity index (CDAI). Gastroenterology 1979; 77: 843-6.
26. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis - a randomized trial. Br Med J 1989; 298: 82-6.
27. Yang J-H, Zhang Y-X, Su C, Sun N-X. Increase of CD4+CD25+ regulatory T cells in peripheral blood of patients with chronic hepatitis C. Shijie Huaren Xiaohua Zazhi 2005; 13: 2201-4.
28. Baecher-Allan C, Hafler DA. Suppressor T cells in human diseases. J Exp Med 2004; 200: 273-6.
29. Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G. Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 1-producing, contact-independent type 1-like regulatory T cells. J Exp Med 2002; 196: 247-53.
30. Levings MK, Bacchetta R, Schulz U, Roncarolo MG. The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int Arch Allergy Immunol 2002; 129: 263-76.
31. Frisullo G, Nociti V, Iorio R etal. Regulatory T cells fail to suppress CD4(+) T-bet(+) T cells in relapsing multiple sclerosis patients. Immunology 2009; 127: 418-28.
32. Suen JL, Li HT, Jong YJ, Chiang BL, Yen JH. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology 2009; 127: 196-205.
33. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor FOXP3. Immunity 2005; 22: 329-41.
34. Maul J, Loddenkemper C, Mundt P etal. Peripheral and intestinal regulatory CD4+CD25(high) T cells in inflammatory bowel disease. Gastroenterology 2005; 128: 1868-78.
35. Yu QT, Saruta M, Avanesyan A, Fleshner PR, Banham AH, Papadakis KA. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis. Inflamm Bowel Dis 2007; 13: 191-9.
36. Schreiber S, MacDermott RP, Raedler A, Pinnau R, Bertovich MJ, Nash GS. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology 1991; 101: 1020-30.
37. Pallone F, Fais S, Squarcia O, Biancone L, Pozzilli P, Boirivant M. Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. Gut 1987; 28: 745-53.
38. Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4(+) CD25(+) regulatory T cells. J Immunol 2003; 170: 3939-43.
39. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4(+)CD25(+) T cell-mediated suppression by dendritic cells. Science 2003; 299: 1033-6.
40. Peng GY, Guo Z, Kiniwa Y etal. Toll-like, receptor 8-mediated reversal of CD4(+) regulatory T cell function. Science 2005; 309: 1380-4.
41. Baecher-Allan C, Viglietta V, Hafler DA. Inhibition of human CD4(+)CD25(+high) regulatory T cell function. J Immunol 2002; 169: 6210-7.